tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Technical Analysis

2,771 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is -0.43, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 125.13, while Sarepta Therapeutics’s (SRPT) share price is $123.05, making it a Sell.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 120.79, while Sarepta Therapeutics’s (SRPT) share price is $123.05, making it a Buy.

Sarepta Therapeutics (SRPT) Pivot Points

Mar 28, 2024, 05:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
116.81
118.69
121.23
123.11
125.65
127.53
130.07
Fibonacci
118.69
120.38
121.42
123.11
124.80
125.84
127.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Mar 28, 2024, 05:19 AM
Period
Simple
Exponential
MA5
122.47Buy
122.95Buy
MA10
122.45Buy
123.94Sell
MA20
128.61Sell
125.13Sell
MA50
122.80Buy
120.79Buy
MA100
105.91Buy
115.52Buy
MA200
111.03Buy
117.31Buy
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 123.94, while Sarepta Therapeutics’s (SRPT) share price is $123.05, making it a Sell.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 115.52, while Sarepta Therapeutics’s (SRPT) share price is $123.05, making it a Buy.
Sarepta Therapeutics’s (SRPT) stock price is $123.05 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 122.80, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $123.05 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 105.91, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $123.05 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 111.03, creating a Buy signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Mar 28, 2024, 05:19 AM
Name
Value
Implied Action
RSI (14)
47.12
Neutral
STOCH (9,6)
41.63
Neutral
STOCHRSI (14)
14.28
Buy
MACD (12,26)
-0.43
Buy
ADX (14)
24.40
Neutral
Williams %R
-85.17
Buy
CCI (14)
-59.21
Neutral
ATR (14)
4.38
-
Ultimate Oscillator
46.17
Neutral
ROC
-10.61
Sell
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 47.12, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 24.40, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is -59.21, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is -10.61, creating a Sell signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Buy.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 47.12, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is -0.43, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 122.47, which suggests SRPT is a Buy.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 128.61, which suggests SRPT is a Sell.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 122.80, which suggests SRPT is a Buy.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 111.03, which suggests SRPT is a Buy.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -85.17, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is -59.21, which suggests SRPT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis